NovaBridge Biosciences
NBPCIK 0001778016 · last filing Jul 8, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
12,432 bought / 4,485 sold
net +7,947 sh · −$4.0K
- buys
- 1
- sells
- 1
- insiders active
- 1
Filing tape
Filed Wed, Jul 8, 2026
- ±0
Gupta Srishti — Chief Executive Officer · Director
- Granted3,000,0002025 Employee Share Option (right to buy)→ 3,000,000 held
Filed Tue, Jul 7, 2026
- +7,947 sh · $4.0K
Xu Cong Claire — SVP, Clinical Development
- Exercised12,432Ordinary Shares→ 302,586 held
- Sold4,485Ordinary Shares@ $0.89→ 298,101 held
- Exercised5,405Restricted Share Units→ 0 held
Insiders on this tape
- Gupta SrishtiChief Executive Officer · Director
- Xu Cong ClaireSVP, Clinical Development
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.